Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human T cells efficiently control RSV infection
Chandrav De, Raymond J. Pickles, Wenbo Yao, et al.
JCI Insight (2023) Vol. 8, Iss. 11
Open Access | Times Cited: 21

Showing 21 citing articles:

Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile
Xian Tang, Wei Zhang, Zheng Zhang
Vaccines (2025) Vol. 13, Iss. 2, pp. 135-135
Open Access | Times Cited: 1
Applications of Organoids in Advancing Drug Discovery and Development
Indiwari Gopallawa, Charu Agrawal, Rayan Jawa, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 9, pp. 2659-2667
Closed Access | Times Cited: 5
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Cameron Bissett, Sandra Belij‐Rammerstorfer, Marta Ulaszewska, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Role of Hypoxia-Inducible Factors in Respiratory Syncytial Virus Infection-Associated Lung Disease
Dorothea R. Morris, Yue Qu, Aline Haas de Mello, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3182-3182
Open Access
Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study
Carlos Fierro, Nelia Sánchez-Crespo, Daniel Makrinos, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unveiling the Mechanism of Kaempferol in RSV-Induced Lung Inflammation through Metabolomics and Network Pharmacology
Sha Zhang, Kerun Cao, Peipei Zhao, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100547-100547
Open Access
Humanized Mouse Systems to Study Viral Infection: A New Era in Immunology Research
Angela Wahl, J. Victor Garcia
Annual Review of Immunology (2025) Vol. 43, Iss. 1, pp. 143-167
Closed Access
T cell-mediated protection in absence of virus neutralizing antibodies
Yeranddy A. Alpízar, Kai Dallmeier
Nature Microbiology (2025)
Closed Access
Recent advances in the prevention and treatment of respiratory syncytial virus disease
Alexandra Sánchez-Martínez, Tom Moore, T. Freitas, et al.
Journal of General Virology (2025) Vol. 106, Iss. 4
Closed Access
Reshaping Our Knowledge: Advancements in Understanding the Immune Response to Human Respiratory Syncytial Virus
Federica Attaianese, S. Guiducci, Sandra Trapani, et al.
Pathogens (2023) Vol. 12, Iss. 9, pp. 1118-1118
Open Access | Times Cited: 7
RSV infection of humanized lung-only mice induces pathological changes resembling severe bronchiolitis and bronchopneumonia
Chandrav De, Raymond J. Pickles, Wenbo Yao, et al.
Frontiers in Virology (2024) Vol. 4
Open Access | Times Cited: 2
A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice
Hong Guo, Yang Song, Hai Li, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 77-77
Open Access | Times Cited: 1
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primates
Aneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Loss of Respiratory Syncytial Virus Antibody Functions During the Peak of the COVID-19 Pandemic Mitigation Measures
Bahaa Abu-Raya, Frederic Reicherz, Christina Michalski, et al.
Journal of the Pediatric Infectious Diseases Society (2023) Vol. 12, Iss. 12, pp. 642-645
Open Access | Times Cited: 3
Non-fatal outcomes of COVID-19 disease in pediatric organ transplantation associates with down-regulation of senescence pathways
Kumar Subramanian, Rency S. Varghese, Molly Pochedly, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
INNBC DApp, a decentralized application to permanently store biomedical data on a modern, proof-of-stake (POS), blockchain such as BNB Smart Chain
Jonathan Fior
BMC Medical Informatics and Decision Making (2024) Vol. 24, Iss. 1
Open Access
Application Value of Serum Cytokines in Respiratory Syncytial Virus Pneumonia in Children
Xinxin Wang, Jiahao Geng, Baowen Li, et al.
SciBase clinical and medical case reports. (2024) Vol. 2, Iss. 1
Open Access
Multiple Questions About Protection From Respiratory Syncytial Virus
Stanley A. Plotkin
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 9, pp. 867-868
Closed Access
Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2
Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1444-1444
Open Access
An oral vaccine based on the Ad5 vector with a double-stranded RNA adjuvant protects mice against respiratory syncytial virus
Pengdi Chai, Yi Shi, Junjie Yu, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113970-113970
Closed Access
Hypoxia-inducible-factors differentially contribute to clinical disease and the control of viral replication during RSV infection
Dorothea R. Morris, Yue Qu, Aline Haas de Mello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top